Bacterial Conjunctivitis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021

Report Code: ZMR-94 | Report Format : | Status : Upcoming |

Abstract

Conjunctivitis is a communicable disease. It is also known as pink eye in the United States and madras eye in India. Conjunctivitis is an inflammation of conjunctiva. Conjunctivitis caused by bacteria, viruses and allergens. It is highly contagious diseases, spread easily through direct contact of any object like towel, napkin or by coughing and sneezing. Bacterial conjunctivitis caused mainly by both gram positive bacteria and gram negative bacteria. Common bacteria responsible for conjunctivitis are taphylococcus aureus, Pseudomonas, Serratia marcescens, Haemophilus influenza etc.

Symptoms of bacterial conjunctivitis are reddening of eyes, excess tears, thick yellow discharge, itching, burning sensation, blurred vision and increase sensitivity towards the light. Treatment includes using antibiotics both systemic and topical. Sometime Povidone-iodine 1.25% ophthalmic solution is also used in African countries like utopia, Uganda as an alternative of antibiotic due to its less cost.

Bacterial conjunctivitis market is driven by increase incidence of conjunctivitis patients across the globe. Exact epidemiology of this disease is difficult to estimate due to its high incidence and low prevalence. Moreover, continuous increasing incidences of bacterial conjunctivitis are responsible for market growth, bacterial conjunctivitis accounts for more than 50% of the cases. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies are expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the bacterial conjunctivitis drug market on a regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the bacterial conjunctivitis drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein product & regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides detailed segmentation of the bacterial conjunctivitis drug market based on product segment and regional segment. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America was the leading segment of bacterial conjunctivitis drug market followed by Europe in 2015. The bacterial conjunctivitis drug market is expected to witness the good growth in the Asia-Pacific region, especially in India and China in the coming years due to the rising population and pandemic nature of conjunctivitis diseases.

Key players included in the report are Allergan, Inc., Merck, Pfizer, Inc., Novartis and others.

This report segments the global bacterial conjunctivitis markets follows:

Bacterial Conjunctivitis Market: Product Segment Analysis

  • Fluoroquinolones
  • Macroloides
  • Aminoglycosides
  • Others

 Bacterial Conjunctivitis Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

Related Reports

Upper Respiratory Tract Treatment Infection Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1720 | Report Format:

Global Upper Respiratory Tract Treatment Infection Market: Overview One of the most common reasons for the people visiting the clinics and hospitals is upper respiratory tract infection. A contagious and acute infection that occurs in the upper respiratory tract is known as upper respiratory tra...Read More

Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1712 | Report Format:

Global Sickle Cell Anemia Treatment Market: Overview A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal cond...Read More

Tuberculosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1702 | Report Format:

Global Tuberculosis Therapeutics Market: Overview Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the...Read More

Systemic Infection Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1701 | Report Format:

Global Systemic Infection Treatment Market: Overview Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the persons bloodstream and gradually spreads to the whole body. The syst...Read More

Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1694 | Report Format:

Global Empty Capsules Market: Overview Empty capsules allow users to fill colorants, bulking agents, and fillers on their own in the capsule. It also permits the user to mix different ingredients together and accordingly decide the specifications of the capsules. Empty capsules are safe, cheaper...Read More

Choose License Type: